These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26219761)

  • 1. Hypocitraturia: a common but not well-known cause of nephrolithiasis.
    Bos S; Nap RR; Wouters RS; van der Kleij FG
    Neth J Med; 2014 Dec; 72(10):545-7. PubMed ID: 26219761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of renal lithiasis with potassium citrate.
    Spivacow FR; Negri AL; Polonsky A; Del Valle EE
    Urology; 2010 Dec; 76(6):1346-9. PubMed ID: 20399488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Citrate and renal stones].
    del Valle EE; Spivacow FR; Negri AL
    Medicina (B Aires); 2013; 73(4):363-8. PubMed ID: 23924538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis.
    Song Y; Hernandez N; Shoag J; Goldfarb DS; Eisner BH
    Urolithiasis; 2016 Apr; 44(2):145-8. PubMed ID: 26582172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocitraturia despite potassium citrate tablet supplementation.
    Shenoy C
    MedGenMed; 2006 Jul; 8(3):8. PubMed ID: 17406150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium nephrolithiasis induced by topiramate.
    Merino-Salas S; Arrabal-Polo MA; Cano-Garcia Mdel C; Arrabal-Martin M
    Arch Esp Urol; 2014 Apr; 67(3):284-7. PubMed ID: 24840594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment Response in Patients with Stones, and Low Urinary pH and Hypocitraturia Stratified by Body Mass Index.
    Astroza GM; Neisius A; Tsivian M; Preminger GM; Lipkin ME
    J Urol; 2016 Mar; 195(3):653-7. PubMed ID: 26393903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkali replacement raises urinary citrate excretion in patients with topiramate-induced hypocitraturia.
    Jhagroo RA; Wertheim ML; Penniston KL
    Br J Clin Pharmacol; 2016 Jan; 81(1):131-6. PubMed ID: 26297809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypocitraturia in children with urolithiasis].
    Kamińska A; Jung A; Piechota W; Kałuza D
    Pol Merkur Lekarski; 2000 Apr; 8(46):181-2. PubMed ID: 10897602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Homeopathic Alternative to Potassium Citrate in Patients With Recurrent Nephrolithiasis.
    Papagiannopoulos D; Holst D; Bechis SK; Sur RL
    Urology; 2018 Sep; 119():35-38. PubMed ID: 29522867
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis.
    Kang DE; Sur RL; Haleblian GE; Fitzsimons NJ; Borawski KM; Preminger GM
    J Urol; 2007 Apr; 177(4):1358-62; discussion 1362; quiz 1591. PubMed ID: 17382731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of potassium citrate delayed preparation in urine PH and citric acid content].
    He HC; Zhong WD; Xie KJ; Dai QS; Zeng GQ; Wei H; Wei HA; Mei H
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1825-6. PubMed ID: 15631783
    [No Abstract]   [Full Text] [Related]  

  • 13. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
    He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
    J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrolithiasis-associated bone disease: pathogenesis and treatment options.
    Sakhaee K; Maalouf NM; Kumar R; Pasch A; Moe OW
    Kidney Int; 2011 Feb; 79(4):393-403. PubMed ID: 21124301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative pilot study of litholytic properties of Celosia argental (Sitivaraka) versus potassium citrate in renal calculus disease.
    Singh RG; Singh TB; Kumar R; Dwivedi US; Moorthy KN; Kumar N
    J Altern Complement Med; 2012 May; 18(5):427-8. PubMed ID: 22537564
    [No Abstract]   [Full Text] [Related]  

  • 16. [Principles of concervative therapy of urolithiasis and prevention of stone formation recurrence].
    Kadyrov ZA; Istratov VG; Suleĭmanov SI
    Klin Med (Mosk); 2007; 85(1):21-6. PubMed ID: 17419350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
    Strohmaier WL; Seilnacht J; Schubert G
    Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation.
    Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM
    J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citraturic, alkalinizing and antioxidative effects of limeade-based regimen in nephrolithiasis patients.
    Tosukhowong P; Yachantha C; Sasivongsbhakdi T; Ratchanon S; Chaisawasdi S; Boonla C; Tungsanga K
    Urol Res; 2008 Aug; 36(3-4):149-55. PubMed ID: 18560820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal dose of potassium citrate in the treatment of children with distal renal tubular acidosis.
    Tapaneya-Olarn W; Khositseth S; Tapaneya-Olarn C; Teerakarnjana N; Chaichanajarernkul U; Stitchantrakul W; Petchthong T
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1143-9. PubMed ID: 12549788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.